| Literature DB >> 28755360 |
Irene C Huffnagel1, Egbert J W Redeker2, Liesbeth Reneman3, Frédéric M Vaz4, Sacha Ferdinandusse4, Bwee Tien Poll-The5.
Abstract
We report the major diagnostic challenge in a female patient with signs and symptoms suggestive of an early-onset mitochondrial encephalopathy. Motor and cognitive development was severely delayed and brain MRI showed signal abnormalities in the putamen and caudate nuclei. Metabolic abnormalities included 3-methylglutaconic aciduria and elevated lactate levels in plasma and cerebrospinal fluid, but were transient. Whole exome sequencing at the age of 25 years finally revealed compound heterozygous mutations c.[229G>C];[563C>T], p.[Glu77Gln];[Ala188Val] in the ECHS1 gene. Activity of short-chain enoyl-CoA hydratase, a mitochondrial enzyme encoded by the ECHS1 gene, was markedly decreased in lymphocytes. Retrospective urine analysis confirms that elevated levels of S-(2-carboxypropyl)cysteamine, S-(2-carboxypropyl)cysteine, and N-acetyl-S-(2-carboxypropyl)cysteine can be a diagnostic clue in the disease spectrum of ECHS1 mutations.Entities:
Keywords: 3-Methylglutaconic aciduria; Developmental disorders; ECHS1; MRI; Mitochondrial disorders; Whole exome sequencing
Year: 2017 PMID: 28755360 PMCID: PMC5953898 DOI: 10.1007/8904_2017_48
Source DB: PubMed Journal: JIMD Rep ISSN: 2192-8304